M
Muin J. Khoury
Researcher at Centers for Disease Control and Prevention
Publications - 523
Citations - 40286
Muin J. Khoury is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Population & Public health. The author has an hindex of 105, co-authored 512 publications receiving 37434 citations. Previous affiliations of Muin J. Khoury include United States Department of Health and Human Services & Université de Montréal.
Papers
More filters
Journal ArticleDOI
Monitoring For Multiple Congenital Anomalies: An International Perspective
Muin J. Khoury,Lorenzo D. Botto,Pierpaolo Mastroiacovo,Rolv Skjærven,Eduardo E. Castilla,J. David Erickson +5 more
Journal ArticleDOI
The Geometric Increase in Meta-Analyses from China in the Genomic Era
John P. A. Ioannidis,Christine Q. Chang,Tram Kim Lam,Sheri D. Schully,Muin J. Khoury,Muin J. Khoury +5 more
TL;DR: There is an urgent global need to incorporate genome-wide data and state-of-the art statistical inferences to avoid a flood of false-positive genetic meta-analyses.
Journal ArticleDOI
Public Awareness and Use of Direct-to-Consumer Genetic Tests: Results From 3 State Population-Based Surveys, 2006
Katrina A. B. Goddard,Debra Duquette,Amy I. Zlot,Jenny Johnson,Ann Annis-Emeott,Patrick W. Lee,Mary Pat Bland,Karen L. Edwards,Kristin Oehlke,Rebecca T. Giles,Ann P. Rafferty,Michelle L. Cook,Muin J. Khoury +12 more
TL;DR: Surveys on direct-to-consumer nutrigenomic testing in Michigan, Oregon, and Utah found awareness of the tests was highest in Oregon and lowest inMichigan, while predictors of awareness were more education, higher income, and increasing age.
Journal ArticleDOI
“Drivers” of Translational Cancer Epidemiology in the 21st Century: Needs and Opportunities
TL;DR: A translational framework influenced by “drivers” that are believed to have begun guiding cancer epidemiology toward translation in the past few years are reviewed and are most likely to drive the field further in the next decade.
Journal ArticleDOI
Trends in utilization and costs of BRCA testing among women aged 18–64 years in the United States, 2003–2014
Zhuo Chen,Katherine Kolor,Scott D. Grosse,Juan L. Rodriguez,Julie Lynch,Julie Lynch,Ridgely Fisk Green,Ridgely Fisk Green,W. David Dotson,M. Scott Bowen,Muin J. Khoury +10 more
TL;DR: The observed trends in BRCA testing rates and costs are consistent with possible effects of several factors, including the Affordable Care Act, clinical guidelines and celebrity publicity.